Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Gross Profit (2016 - 2025)

Historic Gross Profit for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $91.3 million.

  • Veracyte's Gross Profit rose 1553.22% to $91.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $339.3 million, marking a year-over-year increase of 1940.12%. This contributed to the annual value of $298.1 million for FY2024, which is 2980.66% up from last year.
  • Per Veracyte's latest filing, its Gross Profit stood at $91.3 million for Q3 2025, which was up 1553.22% from $89.8 million recorded in Q2 2025.
  • In the past 5 years, Veracyte's Gross Profit registered a high of $91.3 million during Q3 2025, and its lowest value of $20.4 million during Q1 2021.
  • For the 5-year period, Veracyte's Gross Profit averaged around $59.6 million, with its median value being $56.3 million (2023).
  • In the last 5 years, Veracyte's Gross Profit soared by 25432.37% in 2021 and then skyrocketed by 1097.14% in 2024.
  • Quarter analysis of 5 years shows Veracyte's Gross Profit stood at $45.1 million in 2021, then grew by 24.48% to $56.2 million in 2022, then increased by 15.34% to $64.8 million in 2023, then grew by 21.56% to $78.8 million in 2024, then rose by 15.91% to $91.3 million in 2025.
  • Its Gross Profit stands at $91.3 million for Q3 2025, versus $89.8 million for Q2 2025 and $79.5 million for Q1 2025.